Keywords: Sanofi Pasteur, Sanofi-aventis, USA, FDA, Clostridium difficle vaccine

US FDA to fast-track Sanofi Pasteur's investigational Clostridium difficile vaccine

Article | 11 November 2010

Print This

Sanofi Pasteur, the vaccines division of French drug major Sanofi-Aventis (Euronext: SAN), that the US Food and Drug Administration (FDA) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in